HomeBiotechnology Viral Vector Plasmid DNA Manufacturing Market Size, Share and Forecast to 2031
Viral Vector Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Vector-Type (AAV, Retrovirus, Adenovirus, Plasmids, Lentivirus, Others), By Workflow (Upstream {Vector Amplification and Expansion, Vector Recovery/Harvesting}, Downstream {Purification, Fill-Finish}), By Application (Antisense and RNAi, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By End-User (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031
Market Size and Trends
The global viral vector manufacturing market size was valued at USD 355 million in 2022. It is projected to reach USD 1790 million by 2031, growing at a CAGR of 19.7% during the forecast period (2023–2031). Molecula
You will receive a link to download the sample pages on your email immediately after filling out a form
A sample report will help you understand the structure of our full report
The sample shared will be for our off-the-shelf market report
The off-the-shelf report is curated considering a broader audience for this market, we have insights extending well beyond the scope of this report. Please reach out to discuss
Should the sample pages not contain the specific information you seek, we extend the option to request additional details, which our dedicated team will incorporate.
The sample is free of cost, while the full report is available for a fee.